Spatial Biology – News and Features

The collaboration will focus on developing next generation toll-like receptor (TLR) agonists - promising agents that activate innate immune cells and enhance the visibility of cancer tumors.

St. Jude Children’s Research Hospital scientists have discovered evidence of a mechanism at the heart of amyotrophic lateral sclerosis (ALS) and related degenerative diseases. The research appears in the journal Cell and highlights a possible new treatment strategy for the devastating disorders.

Data presented at the Inaugural International Cancer Immunotherapy Conference in New York City.

Scientists have developed a method for simultaneously imaging and identifying dozens of molecules within individual cells.

New study finds protein aggregation after heat exposure is a reversible cellular process, not unrecoverable damage from misfolding.

A new minimally invasive vaccine that combines cancer cells and immune-enhancing factors could be used clinically to launch a destructive attack on tumors.

Collaboration on immuno-oncology combination clinical trial.

A new minimally invasive vaccine that combines cancer cells and immune-enhancing factors could be used clinically to launch a destructive attack on tumors.

Collaboration to Focus on Cancer Immunotherapy Combination of Peregrine's PS-Targeting Bavituximab and AstraZeneca's PD-L1 Inhibitor MEDI4736.

A new statistical method for analyzing next-generation sequencing (NGS) data that helps researchers study the genome of various organisms such as human tumors and could help bring about personalized cancer treatments has been unveiled.